Skip to main content
Top
Published in: Endocrine 1/2020

01-04-2020 | Hypotension | Original Article

Blood pressure evaluated by 24 h ambulatory blood pressure monitoring in Ramadan-fasting patients with corticotrope deficiency

Authors: Melika Chihaoui, Wafa Grira, Fatma Chaker, Ibtissem Oueslati, Zohra Ben Amor, Meriem Yazidi, Moncef Feki

Published in: Endocrine | Issue 1/2020

Login to get access

Abstract

Purpose

The risks of Ramadan fasting on blood pressure (BP) in patients with adrenal insufficiency are unknown. This study aimed to evaluate the levels of BP and particularly the risk for hypotension during a fasting day compared with a nonfasting day in patients with corticotrope deficiency.

Methods

A prospective case-crossover study on 28 patients with known and treated corticotrope deficiency who were fasting the month of Ramadan. Clinical (eating and sleeping habits, abnormal symptoms, weight, height, and BP) and paraclinical (creatinine, sodium, and cortisol) data were collected. Patients had a 24 h ambulatory BP monitoring during a Ramadan fasting day then again during a nonfasting day.

Results

The data of 25 patients were analyzed; 20 women, median age: 40 years (IQR, 22.5–45.5), median duration of the disease: 6 years (IQR, 2.5–12). The prevalence of hypotension did not differ between the fasting day and the nonfasting day. Hour by hour BP levels comparison showed that both systolic and diastolic BP were significantly lower at 2.00 p.m. during fasting. BP variability was significantly lower during the fasting period compared with the same period during the nonfasting day.

Conclusions

Fasting was not associated with an increased risk for hypotension in patients with known and treated corticotrope deficiency.
Literature
7.
go back to reference R. Habbal, L. Azzouzi, K. Adnan, A. Tahiri, N. Chraibi, Variations of blood pressure during the month of Ramadan. Arch. Mal. Coeur Vaiss. 91, 995–998 (1998)PubMed R. Habbal, L. Azzouzi, K. Adnan, A. Tahiri, N. Chraibi, Variations of blood pressure during the month of Ramadan. Arch. Mal. Coeur Vaiss. 91, 995–998 (1998)PubMed
8.
go back to reference G. Perk, J. Ghanem, S. Aamar, D. Ben-Ishay, M. Bursztyn, The effect of the fast of Ramadan on ambulatory blood pressure in treated hypertensives. J. Hum. Hypertens. 15, 723–725 (2001)CrossRef G. Perk, J. Ghanem, S. Aamar, D. Ben-Ishay, M. Bursztyn, The effect of the fast of Ramadan on ambulatory blood pressure in treated hypertensives. J. Hum. Hypertens. 15, 723–725 (2001)CrossRef
9.
go back to reference E. Ural, G. Kozdag, T. Kilic, D. Ural, T. Sahin et al. The effect of Ramadan fasting on ambulatory blood pressure in hypertensive patients using combination drug therapy. J. Hum. Hypertens. 22, 208–210 (2008)CrossRef E. Ural, G. Kozdag, T. Kilic, D. Ural, T. Sahin et al. The effect of Ramadan fasting on ambulatory blood pressure in hypertensive patients using combination drug therapy. J. Hum. Hypertens. 22, 208–210 (2008)CrossRef
11.
go back to reference B. Bernieh, M.R. Al Hakim, Y. Boobes, F.M. Abu Zidan, Fasting Ramadan in chronic kidney disease patients: clinical and biochemical effects. Saudi J. Kidney Dis. Transpl. 21, 898–902 (2010)PubMed B. Bernieh, M.R. Al Hakim, Y. Boobes, F.M. Abu Zidan, Fasting Ramadan in chronic kidney disease patients: clinical and biochemical effects. Saudi J. Kidney Dis. Transpl. 21, 898–902 (2010)PubMed
12.
go back to reference F. Samad, F. Qazi, M.B. Pervaiz, D.K. Kella, M. Mansoor, Effects of Ramadan fasting on blood pressure in normotensive males. J. Ayub Med. Coll. Abbottabad 27, 338–342 (2015)PubMed F. Samad, F. Qazi, M.B. Pervaiz, D.K. Kella, M. Mansoor, Effects of Ramadan fasting on blood pressure in normotensive males. J. Ayub Med. Coll. Abbottabad 27, 338–342 (2015)PubMed
Metadata
Title
Blood pressure evaluated by 24 h ambulatory blood pressure monitoring in Ramadan-fasting patients with corticotrope deficiency
Authors
Melika Chihaoui
Wafa Grira
Fatma Chaker
Ibtissem Oueslati
Zohra Ben Amor
Meriem Yazidi
Moncef Feki
Publication date
01-04-2020
Publisher
Springer US
Published in
Endocrine / Issue 1/2020
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-020-02213-8

Other articles of this Issue 1/2020

Endocrine 1/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.